32.96
price up icon0.46%   0.15
pre-market  Vorhandelsmarkt:  32.66   -0.30   -0.91%
loading

Mbx Biosciences Inc Aktie (MBX) Neueste Nachrichten

pulisher
Apr 13, 2026

Stifel reiterates Buy on MBX Biosciences stock, keeps $50 target - Investing.com

Apr 13, 2026
pulisher
Apr 13, 2026

Is MBX Biosciences Inc stock influenced by commodity pricesWeekly Earnings Recap & Daily Growth Stock Tips - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 12, 2026

Goldman Sachs initiates coverage of MBX Biosciences (MBX) with sell recommendation - MSN

Apr 12, 2026
pulisher
Apr 11, 2026

MBX Biosciences (NASDAQ:MBX) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat

Apr 11, 2026
pulisher
Apr 07, 2026

MBX Biosciences, Inc. focuses on science-led innovation to transform endocrine and metabolic disease treatment - Traders Union

Apr 07, 2026
pulisher
Apr 07, 2026

MBX Biosciences (NASDAQ:MBX) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat

Apr 07, 2026
pulisher
Apr 07, 2026

Institution Moves: Is MBX Biosciences Inc part of any ETF2026 Sector Review & Technical Entry and Exit Tips - baoquankhu1.vn

Apr 07, 2026
pulisher
Apr 04, 2026

Does MBX (MBX) Options-Driven Breakout Reveal Deeper Shifts In Its Investment Narrative? - Yahoo Finance

Apr 04, 2026
pulisher
Apr 04, 2026

MBX Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Sahm

Apr 04, 2026
pulisher
Apr 04, 2026

MBX Biosciences (MBX) Is Up 16.6% After Analyst Initiation And Leadership Award News Has The Bull Case Changed? - Sahm

Apr 04, 2026
pulisher
Apr 03, 2026

MBX Biosciences Approves Equity-Based Inducement Grant for New Employee Under Nasdaq Rule - geneonline.com

Apr 03, 2026
pulisher
Apr 03, 2026

MBX Biosciences Reports Inducement Grant - National Today

Apr 03, 2026
pulisher
Apr 03, 2026

Lifesci Capital Weighs in on MBX Biosciences Q1 Earnings - MarketBeat

Apr 03, 2026
pulisher
Apr 02, 2026

MBX Biosciences (NASDAQ:MBX) Upgraded at Lifesci Capital - MarketBeat

Apr 02, 2026
pulisher
Mar 31, 2026

MBX Biosciences (NASDAQ:MBX) Shares Up 8.5%What's Next? - MarketBeat

Mar 31, 2026
pulisher
Mar 30, 2026

MBX Biosciences, Inc. (NASDAQ:MBX) Sees Large Increase in Short Interest - MarketBeat

Mar 30, 2026
pulisher
Mar 29, 2026

MBX PE Ratio & Valuation, Is MBX Overvalued - Intellectia AI

Mar 29, 2026
pulisher
Mar 29, 2026

221,672 Shares in MBX Biosciences, Inc. $MBX Acquired by Goelzer Investment Management Inc. - MarketBeat

Mar 29, 2026
pulisher
Mar 26, 2026

MBX CEO Buys 18,500 Shares as Stock Jumps 270% This Past Year. Here's What You Should Know - Yahoo Finance

Mar 26, 2026
pulisher
Mar 26, 2026

Wall Street Analysts See a 280.14% Upside in MBX Biosciences, Inc. (MBX): Can the Stock Really Move This High? - MSN

Mar 26, 2026
pulisher
Mar 26, 2026

MBX Biosciences, Inc. (NASDAQ:MBX) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Mar 26, 2026
pulisher
Mar 25, 2026

MBX (NASDAQ: MBX) affiliate files sale notice for 1,061 vested shares - Stock Titan

Mar 25, 2026
pulisher
Mar 25, 2026

MBX Biosciences (MBX) Is Down 6.5% After Wider Losses And New Shelf Filings Has The Bull Case Changed? - simplywall.st

Mar 25, 2026
pulisher
Mar 23, 2026

Hudson Bay Capital Management LP Purchases New Stake in MBX Biosciences, Inc. $MBX - MarketBeat

Mar 23, 2026
pulisher
Mar 22, 2026

Aug Intraday: Can MBX Biosciences Inc keep up with sector leaders2026 Risk Factors & AI Powered Trade Plan Recommendations - baoquankhu1.vn

Mar 22, 2026
pulisher
Mar 20, 2026

MBX Biosciences Advances Avail Phase 2 Trial in Hypoparathyroidism: What Investors Should Watch - TipRanks

Mar 20, 2026
pulisher
Mar 19, 2026

Top MBX Biosciences (MBX) Competitors 2026 - MarketBeat

Mar 19, 2026
pulisher
Mar 19, 2026

New weekly therapy moves toward Phase 3 for hypoparathyroidism - Hypoparathyroidism News

Mar 19, 2026
pulisher
Mar 18, 2026

MBX Biosciences (MBX) CFO John Smither files initial Form 3 - Stock Titan

Mar 18, 2026
pulisher
Mar 17, 2026

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Mar 17, 2026
pulisher
Mar 17, 2026

MBX Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 17, 2026
pulisher
Mar 16, 2026

MBX Biosciences Chief Makes Bold Insider Move With Major Stock Buy - TipRanks

Mar 16, 2026
pulisher
Mar 16, 2026

Company (NASDAQ: MBX) Form 144 — 10,000-share sale notice via Fidelity - Stock Titan

Mar 16, 2026
pulisher
Mar 16, 2026

MBX Biosciences (NASDAQ:MBX) Shares Gap Up After Insider Buying Activity - MarketBeat

Mar 16, 2026
pulisher
Mar 16, 2026

A Look At MBX Biosciences (MBX) Valuation After Recent Share Price Pullback - simplywall.st

Mar 16, 2026
pulisher
Mar 16, 2026

Hawryluk P. Kent buys MBX Biosciences shares worth $525,662 By Investing.com - Investing.com India

Mar 16, 2026
pulisher
Mar 16, 2026

Hawryluk P. Kent buys MBX Biosciences shares worth $525,662 - Investing.com

Mar 16, 2026
pulisher
Mar 16, 2026

MBX Biosciences (NASDAQ:MBX) CEO Buys $525,585.00 in Stock - MarketBeat

Mar 16, 2026
pulisher
Mar 16, 2026

MBX Biosciences (MBX) CEO adds 18,500 shares via trust purchase - Stock Titan

Mar 16, 2026
pulisher
Mar 16, 2026

MBX Phase 3 Plans And New CBO Sharpen Rare Disease Focus - Yahoo Finance

Mar 16, 2026
pulisher
Mar 15, 2026

Baker BROS. Advisors LP Takes $4.86 Million Position in MBX Biosciences, Inc. $MBX - MarketBeat

Mar 15, 2026
pulisher
Mar 14, 2026

MBX Biosciences completes FDA meeting for Phase 3 trial design - Investing.com Nigeria

Mar 14, 2026
pulisher
Mar 14, 2026

Ghisallo Capital Management LLC Takes $669,000 Position in MBX Biosciences, Inc. $MBX - MarketBeat

Mar 14, 2026
pulisher
Mar 14, 2026

Wall Street Analysts See a 142% Upside in MBX Biosciences, Inc. (MBX): Can the Stock Really Move This High? - MSN

Mar 14, 2026
pulisher
Mar 13, 2026

Analysts Offer Insights on Healthcare Companies: MBX Biosciences, Inc. (MBX) and REPRO-MED Systems (KRMD) - The Globe and Mail

Mar 13, 2026
pulisher
Mar 13, 2026

MBX Biosciences Inc expected to post a loss of 58 cents a shareEarnings Preview - TradingView

Mar 13, 2026
pulisher
Mar 13, 2026

Citizens reiterates Market Outperform on MBX Biosciences stock - Investing.com Nigeria

Mar 13, 2026
$54.26
price up icon 2.69%
$48.70
price down icon 0.25%
$99.47
price up icon 1.08%
$152.54
price up icon 3.76%
$146.74
price down icon 4.34%
ONC ONC
$319.94
price up icon 3.21%
Kapitalisierung:     |  Volumen (24h):